首页> 外文OA文献 >P1.04-67 First-Line Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer (NSCLC) – A Network Meta-Analysis by PD-L1

【2h】

P1.04-67 First-Line Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer (NSCLC) – A Network Meta-Analysis by PD-L1

机译：P1.04-67先进的非小细胞肺癌（NSCLC）中的一线免疫检查点抑制剂 - PD-L1的网络元分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

AI期刊论文写作 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
P. San Tan; P. Nazareth Aguiar Junior; M. Husnain; B. Haaland; G. Lopes;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1/PD-L1 immune checkpoint blockers [J] . Soleine Medjebar, Caroline Truntzer, Ana?s Perrichet, Oncoimmunology. . 2020,第1期

机译：血管紧张素转换酶（ACE）抑制剂处方会影响非小细胞肺癌（NSCLC）患者对PD-1 / PD-L1免疫检查点阻断剂的反应
2. First-line immune checkpoint inhibitors for advanced non-small cell lung cancer with wild-type epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK): a systematic review and network meta-analysis [J] . Tingting Liu, Silu Ding, Jun Dang, Journal of Thoracic Disease . 2019,第7期

机译：具有野生型表皮生长因子受体（EGFR）或间变性淋巴瘤激酶（ALK）的晚期非小细胞肺癌的一线免疫检查点抑制剂：系统评价和网络荟萃分析
3. Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis [J] . Urania Dafhi Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2019,第1期

机译：免疫检查点抑制剂，单独或与化疗组合，作为先进的非小细胞肺癌的一线治疗。系统审查和网络元分析
4. Diagnosis of lymph node metastasis in non-small-cell lung cancer (NSCLC) patient on F-18-FDG PET/CT [C] . Tsu-Chi Cheng, Nan-Tsing Chiu, Ting-Yu Su, International Forum on Medical Imaging in Asia 2019 . 2019

机译：F-18-FDG PET / CT诊断非小细胞肺癌（NSCLC）淋巴结转移
5. Use of Palliative Radiotherapy Among Metastatic Non-small-cell Lung Cancer (NSCLC) Patients in Puerto Rico [D] . ?Quinones Avila, Valerie 2020

机译：在波多黎各的转移性非小细胞肺癌（NSCLC）患者中使用姑息放射治疗
6. Comparative Efficacy and Safety of Anti-PD-1/PD-L1 Immune Checkpoint Inhibitors for Refractory or Relapsed Advanced Non-Small-Cell Lung Cancer—A Systematic Review and Network Meta-Analysis [O] . Koichi Ando, Ryo Manabe, Yasunari Kishino, 2021

机译：抗PD-1 / PD-L1免疫检查点抑制剂对难治性或复发先进的非小细胞肺癌的比较疗效和安全性 - 一种系统综述和网络元分析
7. Comparative Efficacy and Safety of Anti-PD-1/PD-L1 Immune Checkpoint Inhibitors for Refractory or Relapsed Advanced Non-Small-Cell Lung Cancer—A Systematic Review and Network Meta-Analysis [O] . Koichi Ando, Ryo Manabe, Yasunari Kishino, 2020

机译：抗PD-1 / PD-L1免疫检查点抑制剂对难治性或复发先进的非小细胞肺癌的比较疗效和安全性 - 一种系统综述和网络元分析

P1.04-67 First-Line Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer (NSCLC) – A Network Meta-Analysis by PD-L1

著录项

引文网络

相似文献

相关主题

期刊订阅